JESSICA LISTORTI: Open Payments
NPI 1275177404 · BLOOMFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 34 payments from 5 companies in 2025. Trend: 2023 $400 · 2024 $408 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $249 |
| Gilead Sciences, Inc. | 1 | $57 |
| Alkermes, Inc. | 1 | $28 |
| Indivior Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: VRAYLAR, Epclusa, VIVITROL, SUBLOCADE, COBENFY.
Industry payments across CT — which companies pay providers there.
